What is the CPT code for a robot-assisted minimally invasive Ivor Lewis esophagectomy performed for distal esophageal adenocarcinoma in a patient on postoperative day 3?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CPT Code for Robot-Assisted Minimally Invasive Ivor Lewis Esophagectomy

The appropriate CPT code for a robot-assisted minimally invasive Ivor Lewis esophagectomy performed for distal esophageal adenocarcinoma is CPT 43287 (Esophagectomy, distal two-thirds, with thoracotomy and separate abdominal incision, with or without proximal gastrectomy; with thoracic esophagogastrostomy, with or without pyloroplasty [Ivor Lewis]).

Key Coding Considerations

The Ivor Lewis esophagectomy is a two-phase procedure involving:

  • Abdominal phase: Mobilization of the stomach to create a gastric conduit, with dissection of celiac and left gastric lymph nodes 1
  • Thoracic phase: Right thoracotomy (or thoracoscopic) approach with esophageal resection and upper thoracic esophagogastric anastomosis at or above the azygos vein 1

Robot-Assisted Approach Coding

Robot-assisted minimally invasive esophagogastrectomy is recognized as an acceptable operative approach for resectable esophageal or esophagogastric junction cancer 1. The procedure described combines:

  • Laparoscopic abdominal mobilization
  • Robotic thoracic dissection and anastomosis

Recent evidence demonstrates that minimally invasive esophagectomy (including robotic techniques) is associated with lower postoperative morbidity, reduced pneumonia rates, and improved short-term quality of life compared to open approaches, with equivalent oncologic outcomes 2, 3.

Important Coding Caveats

Do Not Use Separate Robotic Codes

The CPT code 43287 encompasses the entire Ivor Lewis procedure regardless of whether it is performed open, laparoscopic, or robot-assisted. Do not separately code for robotic assistance - this is included in the primary procedure code.

Additional Codes to Consider

  • CPT 38746 or 38747 may be appropriate for extensive lymphadenectomy if performed beyond standard dissection (at least 15 lymph nodes should be removed for adequate staging 1)
  • CPT 44015 for jejunostomy tube placement if performed (commonly done during the abdominal phase 1)

Postoperative Day 3 Documentation

Since the patient is on postoperative day 3, ensure documentation includes:

  • Global surgical period management (CPT 43287 includes 90-day global period)
  • Any complications requiring separate coding (anastomotic leak, pneumonia, etc.)
  • Routine postoperative care is bundled and not separately billable

Clinical Context from Guidelines

The robot-assisted Ivor Lewis approach is particularly appropriate for distal esophageal adenocarcinoma as it:

  • Provides adequate proximal margin for distal tumors 1
  • Allows for thorough two-field lymphadenectomy 2, 1
  • Achieves R0 resection rates of 92-96% with median lymph node yields of 23-47 nodes 4, 5, 6, 7
  • Results in anastomotic leak rates of 3-8% and stricture rates of 7-27% 5, 6, 7, 8

The procedure should be performed in high-volume esophageal centers by experienced surgeons 1, with outcomes improving significantly after 50-100 cases 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.